INMED LLC.

Company Snapshot

Founded: 2010

Entity Type: Private

Region: Russia

Headquarter: St. Petersburg, Russia

Key Geographics: Europe

Corporate Address: 34 Svyazi St. Letter A, Strelna St. Petersburg 198515 Russia Tel. +7-812-385-1415 www.nanofibers.tech

Company Overview

Inmed LLC develops and produces nanofiber materials for various fields, such as nanocatalysis, tissue engineering scaffolds, healthcare, filtration, optical electronics, etc. The company operates through different areas united by electrospinning technology, including Trivent, Multi-Layer Textile, Hemoflex, and Filtration Materials.

INMED LLC. In Reports

Global Markets and Technologies for Nanofibers

BCC Research Market Analyst says global market for nanofibers is estimated to increase from $2.9 billion in 2023 to reach $9.4 billion by 2028, at a CAGR of 26.0%.

Global Markets and Technologies for Nanofibers

BCC Research Market Report for Global Nanofibers Market. Forecast the global nanofibers market size, projected growth trends, and corresponding market share analysis by material, application, and region

View All Reports

INMED LLC. In News

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update - Newsfile

Newsfile - Sep 23, 2025

InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules - Investing News Network

Investing News Network - Jun 27, 2025

InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025 - GlobeNewswire

GlobeNewswire - Sep 16, 2025

InMed’s INM-901 Demonstrates Potential as a Multi-factorial Approach to Treating Alzheimer’s Disease - Fierce Biotech

Fierce Biotech - Jul 22, 2024

Read All News

Company's Business Segments

Electrospinning : The company develop and manufacture nanofiber materials for various applications.

Applications/End User Industries

Nanocatalysis
Tissue Engineering Scaffolds
Healthcare

Filtration
Optical Electronics